Current evidence linking polyunsaturated fatty acids (PUFAs) with cancer risk and progression
There is increasing evidence that polyunsaturated fatty acids (PUFAs) play a role in cancer risk and progression. The n-3 family of PUFAs includes alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) while the n-6 family includes linolenic acid (LA) and arachidonic...
Main Authors: | Maria eAzrad, Chelsea Elizabeth Turgeon, Wendy eDemark-Wahnefried |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00224/full |
Similar Items
-
Design and analysis of clinical trials with time-to-event endpoints /
by: Peace, Karl E., 1941-
Published: (c200) -
Handbook of adaptive designs in pharmaceutical and clinical development /
by: Pong, Annpey, et al.
Published: (2011) -
Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping Review
by: Beate Aurich, et al.
Published: (2021-05-01) -
Addressing Knowledge Gaps in the Primary Prevention of Atherosclerotic Heart Disease
by: Samuel S. Gidding
Published: (2024-03-01) -
A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis
by: Francisco A. Kerdel, et al.
Published: (2019-05-01)